Evidence map›Paper›PMID 31891564›Full record

ArticleJournal of hospital medicine2020

Antibiotics for Aspiration Pneumonia in Neurologically Impaired Children.

Joanna Thomson, Matt Hall, Lilliam Ambroggio, Jay G Berry, Bryan Stone, Rajendu Srivastava, Samir S Shah

Abstract readMulticenter Study
In one paragraph

Article in Journal of hospital medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Management of Pediatric Pneumonia: A Decade After the Pediatric Infectious Diseases Society and Infectious Diseases Society of America Guideline.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Joanna ThomsonDivision of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Matt HallChildren's Hospital Association, Lenexa, Kansas.
Lilliam AmbroggioSections of Emergency Medicine and Hospital Medicine, Children's Hospital Colorado, Department of Pediatrics, University of Colorado.
Jay G BerryDivision of General Pediatrics, Children's Hospital Boston, Boston, Massachusetts.
Bryan StoneDivision of Inpatient Medicine, Primary Children's Hospital, Intermountain Health Care, Salt Lake City, Utah.
Rajendu SrivastavaDivision of Inpatient Medicine, Primary Children's Hospital, Intermountain Health Care, Salt Lake City, Utah.
Samir S ShahDivision of Hospital Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Funding

Hospital Management of Acute Respiratory Illness in Children with Neurologic Impairment.K08HS025138 · AHRQ · CINCINNATI CHILDRENS HOSP MED CTR · PI THOMSON, JOANNA · 2017 to 2021
$741k
Metabolomics Evaluation of the Etiology of PneumoniaK01AI125413 · NIAID · UNIVERSITY OF COLORADO DENVER · PI AMBROGGIO, LILLIAM · 2017 to 2021
$641k
AHRQ HHS K08 HS025138NIAID NIH HHS K01 AI125413
6 · The paper itself

Abstract

objectiveTo compare hospital outcomes associated with commonly used antibiotic therapies for aspiration pneumonia in children with neurologic impairment (NI). DESIGN/

methodsA retrospective study of children with NI hospitalized with aspiration pneumonia at 39 children's hospitals in the Pediatric Health Information System database. Exposure was empiric antibiotic therapy classified by antimicrobial activity. Outcomes included acute respiratory failure, intensive care unit (ICU) transfer, and hospital length of stay (LOS). Multivariable regression evaluated associations between exposure and outcomes and adjusted for confounders, including medical complexity and acute illness severity.

resultsIn the adjusted analysis, children receiving Gram-negative coverage alone had two-fold greater odds of respiratory failure (odds ratio [OR] 2.15; 95% CI: 1.41-3.27), greater odds of ICU transfer (OR 1.80; 95% CI: 1.03-3.14), and longer LOS [adjusted rate ratio (RR) 1.28; 95% CI: 1.16-1.41] than those receiving anaerobic coverage alone. Children receiving anaerobic and Gram-negative coverage had higher odds of respiratory failure (OR 1.65; 95% CI: 1.19-2.28) than those receiving anaerobic coverage alone, but ICU transfer (OR 1.15; 95% CI: 0.73-1.80) and length of stay (RR 1.07; 95% CI: 0.98-1.16) did not statistically differ. For children receiving anaerobic, Gram-negative, and P. aeruginosa coverage, LOS was shorter (RR 0.83; 95% CI: 0.76-0.90) than those receiving anaerobic coverage alone; odds of respiratory failure and ICU transfer rates did not significantly differ.

conclusionsAnaerobic therapy appears to be important in the treatment of aspiration pneumonia in children with NI. While Gram-negative coverage alone was associated with worse outcomes, its addition to anaerobic therapy may not yield improved outcomes.

Indexed as

Anti-Bacterial AgentsCentral Nervous System DiseasesChild, PreschoolFemaleHospitalizationHospitals, PediatricHumansIntensive Care UnitsLength of StayMalePneumocystis InfectionsPneumonia, AspirationRespiratory InsufficiencyRetrospective StudiesAnti-Bacterial Agents

Identifiers

PMID31891564
PMCPMC7641495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.